Skip to main content

Table 3 Serum levels of ANCA and ASCA in UC patients with different disease locations

From: Assessment of clinical activity and severity using serum ANCA and ASCA antibodies in patients with ulcerative colitis

Disease locations

N

ANCA-IgG

ASCA-IgA

ASCA-IgG

Whole colon type

42

19.90 ± 36.00

1.45 ± 6.68

4.36 ± 6.68

Left colon type

32

20.76 ± 34.57

3.45 ± 15.90

2.90 ± 5.99

Rectal type

31

10.97 ± 13.15

1.46 ± 3.05

3.36 ± 5.12

  1. The levels of serum ANCA and ASCA in patients within the whole colon type group, left colon type group and rectal type group were compared, and no significant difference with each other were observed (p > 0.05). Antibody levels are U/mL (mean ± SD)